about
Prevalence of comorbidity of chronic diseases in AustraliaQuality of pharmaceutical advertisements in medical journals: a systematic reviewInformation from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic reviewQuality and availability of consumer information on heart failure in Australia.Self-medication with over-the-counter drugs and complementary medications in South Australia's elderly populationPrasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data.Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort studyMedicines information provided by pharmaceutical representatives: a comparative study in Australia and MalaysiaAnalgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: a cross-sectional, multisite, epidemiological study protocol.Co-morbidity and potential treatment conflicts in elderly heart failure patients: a retrospective, cross-sectional study of administrative claims data.Drug marketing in French-speaking African countries.Comorbid chronic diseases, discordant impact on mortality in older people: a 14-year longitudinal population study.Response to Michael Wonder's comments on the article 'Assessment of the therapeutic value of new medicines marketed in Australia'Evaluating medication-related quality of care in residential aged care: a systematic review.Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study.Access to new cancer medicines in Australia: dispelling the myths and informing a public debate.Comorbid diabetes and COPD: impact of corticosteroid use on diabetes complications.Influence of medication risks and benefits on treatment preferences in older patients with multimorbidity.Assessment of the therapeutic value of new medicines marketed in AustraliaChronic disease management: does the disease affect likelihood of care planning?Does antidepressant medication use affect persistence with diabetes medicines?Longitudinal trends in utilization of endocrine therapies for breast cancer: an international comparison.Trends in general practitioner services to residents in aged care.Disease burden, comorbidity and geriatric syndromes in the Australian aged care population.Availability, Price, and Affordability of Selected Essential Medicines for Chronic Diseases in 11 Countries of the Asia Pacific Region: A Secondary Analysis.Comorbidity, physical and mental health among cancer patients and survivors: An Australian population-based study.Ten years of publicly funded biological disease-modifying antirheumatic drugs in Australia.Effect of a general practitioner management plan on health outcomes and hospitalisations in older patients with diabetes.Analgesic use and pain in residents with and without dementia in aged care facilities: A cross-sectional study.Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting.Provision of medicines information in Australian community pharmacies.Is Australia's national medicines policy failing? The case of COX-2 inhibitors.Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study.Transparency is good, independence from pharmaceutical industry is better!Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States.Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing?Reporting of studies on new medicines in major medical journals: a case study in breast cancer.Time and geographical variations in utilization of endocrine therapy for breast cancer in Australia.Provision of information on regulatory authorities' websites.Validity of medication-based co-morbidity indices in the Australian elderly population.
P50
Q24657304-E1B24AA4-9A07-44BF-99A1-EB35DD3D4C25Q28475792-C06709CF-A535-4EB5-BA7C-50F9C3FFABF6Q28475841-0A2BC972-CC4D-41AE-9EE0-24BB764CC80DQ33392459-1D717B27-2FE5-4171-9895-DC347217E1D2Q33515780-7807A50D-59E1-4677-B43B-C12316A6A3BEQ33584173-D3BF80F8-1DBB-4735-9658-ED2AABC31D38Q33754547-07008465-30F7-441A-B092-AF3A21F15BD3Q33759116-18F8521A-A6E1-45FC-B2A9-E14DE6497292Q33795585-D082C4B8-E8CA-49A1-B17C-19A6DA34C65CQ33948375-96E701B1-E073-4B5A-9ACD-777521902C17Q34729442-EBB960F2-0CD2-4B8F-BCAD-B7683293E265Q35009417-C38FBEA4-59CB-4BA5-B5FE-040FB3CEDCCDQ35198442-7499008C-7CB4-4D3D-8EE8-68E2F1903ABDQ35685992-742FCC29-776D-4F80-AEAE-969E1AAF566EQ36174876-B44BD647-0607-4D60-B734-02635ABD7AF4Q36774740-6FA87CC3-5D18-43BA-85C5-975D5DC78B22Q37193551-8152FAE1-8041-404E-BEA1-4415FF6FEF50Q37608563-06C9CE15-2476-4BBE-B0D5-AC99F3366D4CQ37703341-76A38422-906F-4DF4-87DF-954AE2D84F21Q38051829-27E70886-7F21-423A-AA8A-7BBBB262A7B9Q38085270-CB9B06EB-4CB6-4022-A186-483FA4E0B676Q38264861-4C8BAEE9-9279-48EB-9D6F-CD18B0BBF798Q38828532-56A3A32C-509C-459E-993B-C43B40A6CF69Q38841053-6235395C-B83C-4BC6-AE2E-76AFB2D62A58Q38843019-995AE761-0964-41CB-9C2A-9988E5D98654Q38858796-CBE8F4F6-8FCA-4F52-BC7B-57749EE282E2Q38915072-1F822101-E3E5-40CE-AF1B-A396B68ADDBBQ38934945-CEB243FF-B046-45DC-853C-1AC11B8C29B5Q39713164-4DADB2BE-E9CE-4765-9EC5-9880C48E6727Q39803528-23041D94-4CCC-4969-9D78-9541AB4728BFQ39874516-36ED69EA-986E-426D-8FC8-A5543EBB280CQ40145356-24A196CA-929A-4D08-A2EA-48734C68069EQ40209626-41C67B9B-3C64-4DF8-AC6E-006A00CD620AQ42341000-F6B9BF20-2DC5-4663-ACBB-B4822F499137Q42739479-8B681697-6E35-4972-968A-E84930856E12Q42972921-A5B51688-ACB7-4C4C-BA2B-A8F610A4BE6DQ43122611-06068924-835D-4FF0-9C56-9257601F25E8Q43571676-709EA067-3130-40D5-8F5F-2ACF3A188776Q43691931-4ADE4F75-44CE-432A-B40E-18C2D5BB5292Q43793895-C1E5EEA7-698A-4044-936C-56AF71AB0DB5
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Agnes I. Vitry
@ast
Agnes I. Vitry
@en
Agnes I. Vitry
@es
Agnes I. Vitry
@nl
type
label
Agnes I. Vitry
@ast
Agnes I. Vitry
@en
Agnes I. Vitry
@es
Agnes I. Vitry
@nl
prefLabel
Agnes I. Vitry
@ast
Agnes I. Vitry
@en
Agnes I. Vitry
@es
Agnes I. Vitry
@nl
P1053
G-2822-2010
P106
P1153
6602702228
P21
P31
P3829
P496
0000-0003-1091-6453